BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 2654494)

  • 1. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T; Muus P; Haanen C; Van der Lely N; Koekman E; Van der Locht A; Blankenborg G; Wessels J
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P; Wang C; Curtis JE; McCulloch EA
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitro.
    Gao XZ; Yin MY; Preisler HD
    Anticancer Res; 1989; 9(4):1053-5. PubMed ID: 2683990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
    Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia.
    Gandhi V; Du M; Kantarjian HM; Plunkett W
    Leukemia; 1994 Sep; 8(9):1463-8. PubMed ID: 8090026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
    Andreeff M; Tafuri A; Hegewisch-Becker S
    Haematol Blood Transfus; 1990; 33():747-62. PubMed ID: 2323674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
    Miyauchi J; Kelleher CA; Wong GG; Yang YC; Clark SC; Minkin S; Minden MD; McCulloch EA
    Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
    Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
    Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.
    Van der Lely N; De Witte T; Wessels J; Raymakers R; Muus P; Preijers F
    Ann Hematol; 1994 May; 68(5):225-32. PubMed ID: 7517190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.